To identify therapeutically relevant genes and pathways in prostate carcinogenesis, changes in cell viability and induction of apoptosis (caspase -3 and 7 activation) were studied as the end-points (Supporting Table S2). This evidence concerns the gene CASP3 and prostatitis.